- Release Date: 17/04/23 08:24
- Summary: Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma
- Price Sensitive: Yes
- Download Document 245.57KB
- Forums
- ASX - By Stock
- Ann: Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma
IMM
immutep limited
Add to My Watchlist
13.0%
!
26.0¢

Ann: Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.030(13.0%) |
Mkt cap ! $374.3M |
Open | High | Low | Value | Volume |
23.5¢ | 26.3¢ | 23.3¢ | $945.3K | 3.750M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 90985 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 14381 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 90985 | 0.275 |
1 | 7102 | 0.265 |
1 | 527256 | 0.260 |
1 | 39000 | 0.255 |
4 | 83240 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 14381 | 2 |
0.255 | 2469 | 1 |
0.260 | 101493 | 4 |
0.265 | 837042 | 10 |
0.270 | 597443 | 10 |
Last trade - 15.58pm 15/09/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online